$8M deal sees Private Lantheus pick up 12.16% of Radiopharm Theranostics
Private entity Lantheus, a similarly minded healthcare player, has acquired just over…
Radiopharm Theranostics Limited (ASX:RAD)
About Radiopharm Theranostics Limited
Key Information
RAD In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 13.18pm 21/01/2025 | Notice Under Section 708A | 123.87KB | 162 |
| 13.15pm 21/01/2025 | Application for quotation of securities - RAD | 16.46KB | 167 |
| 20/01/2025 | Response to ASX Cleansing Notice Validity Letter | 873.22KB | 302 |
| 10/01/2025 | Price Sensitive PS Lantheus increases shareholding in RAD with A$8m placement | 89.1KB | 38K |
| 30/12/2024 | Price Sensitive PS Strategic Co-Development Partnership with Lantheus for Aus | 159.85KB | 5.2K |
| 20/12/2024 | Price Sensitive PS RAD 202 receives approval to start Phase 1 therapeutic trial | 88.43KB | 2.8K |
| 19/12/2024 | Notice Under Section 708A | 145.27KB | 526 |
| 19/12/2024 | Application for quotation of securities - RAD | 17.64KB | 779 |